Concordance of FDG PET/CT metabolic tumour volume versus DW-MRI functional tumour volume with T2-weighted anatomical tumour volume in cervical cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Concordance of FDG PET/CT metabolic tumour volume versus DW-MRI functional tumour volume with T2-weighted anatomical tumour volume in cervical cancer ; volume:17 ; number:1 ; day:6 ; month:12 ; year:2017 ; pages:1-8 ; date:12.2017
BMC cancer ; 17, Heft 1 (6.12.2017), 1-8, 12.2017
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-017-3800-9
- URN
-
urn:nbn:de:101:1-2019061421580990612562
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lai Yee Tak, Alta
- Perucho, Jose A. U.
- Xu, Xiaopei
- Hui, Edward S.
- Lee, Elaine Y. P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Estimation of tumour volume at therapy initiation by back-extrapolating the post-therapy regression curve of tumour volume
Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients
Breast and Tumour Volume Measurements in Breast Cancer Patients Using 3-D Automated Breast Volume Scanner Images
Size matters: integrating tumour volume and immune activation signatures predicts immunotherapy response
The significance of partial volume effect on the estimation of hypoxic tumour volume with [18F]FMISO PET/CT
The impact of MRI sequence on tumour staging and gross tumour volume delineation in squamous cell carcinoma of the anal canal
PrognosiT: Pathway/gene set-based tumour volume prediction using multiple kernel learning
Harmonization of nomenclature for molecular imaging metrics of tumour burden: molecular tumour volume (MTV), total lesion activity (TLA) and total lesion fraction (TLF)
Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC
Use of Imaging to Optimise Prostate Cancer Tumour Volume Assessment for Focal Therapy Planning
Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma
Large tumour volume reduction of IDH-mutated anaplastic glioma involving the insular region following radiotherapy
Estimation of tumour volume at therapy initiation by back-extrapolating the post-therapy regression curve of tumour volume
Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients
Breast and Tumour Volume Measurements in Breast Cancer Patients Using 3-D Automated Breast Volume Scanner Images
Size matters: integrating tumour volume and immune activation signatures predicts immunotherapy response
The significance of partial volume effect on the estimation of hypoxic tumour volume with [18F]FMISO PET/CT
The impact of MRI sequence on tumour staging and gross tumour volume delineation in squamous cell carcinoma of the anal canal
PrognosiT: Pathway/gene set-based tumour volume prediction using multiple kernel learning
Harmonization of nomenclature for molecular imaging metrics of tumour burden: molecular tumour volume (MTV), total lesion activity (TLA) and total lesion fraction (TLF)
Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC
Use of Imaging to Optimise Prostate Cancer Tumour Volume Assessment for Focal Therapy Planning
Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma
Large tumour volume reduction of IDH-mutated anaplastic glioma involving the insular region following radiotherapy
Estimation of tumour volume at therapy initiation by back-extrapolating the post-therapy regression curve of tumour volume
Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients
Breast and Tumour Volume Measurements in Breast Cancer Patients Using 3-D Automated Breast Volume Scanner Images
Size matters: integrating tumour volume and immune activation signatures predicts immunotherapy response
The significance of partial volume effect on the estimation of hypoxic tumour volume with [18F]FMISO PET/CT
The impact of MRI sequence on tumour staging and gross tumour volume delineation in squamous cell carcinoma of the anal canal
PrognosiT: Pathway/gene set-based tumour volume prediction using multiple kernel learning
Harmonization of nomenclature for molecular imaging metrics of tumour burden: molecular tumour volume (MTV), total lesion activity (TLA) and total lesion fraction (TLF)
Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC
Use of Imaging to Optimise Prostate Cancer Tumour Volume Assessment for Focal Therapy Planning
Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma